Abstract
We describe a patient who had nine primary malignant tumors and a germline mutation in the p53 tumor-suppressor gene, characteristically found in the Li-Fraumeni syndrome (LFS). A 15-year-old girl with no family history of cancer was referred to our hospital because of pain and swelling of the right knee. Osteosarcoma was diagnosed. The patient received chemotherapy followed by surgery and had a remission. After the age of 28 years, nine primary malignant tumors developed successively, including right breast cancer, colon cancer, malignant fibrous histiocytoma (MFH) of the abdominal wall, right lung double cancers, bilateral breast cancers, and MFH of the left thigh. This is the second highest number of types of primary malignant tumors to be reported in LFS. All tumors were treated by a multidisciplinary approach, including surgery. Genetic analysis revealed a germline missense mutation in the p53 gene (c.659 A > G), resulting in Y220C, which has been reported in three families with LFS. The patient died of lung metastasis from MFH at the age of 37 years. Despite the multiple tumors, repeated induction of remissions resulted in long survival. Our findings suggest that a multidisciplinary approach to treatment, including surgery, is beneficial in patients with LFS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Li FP, Fraumeni JF (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71:747–752
Li FP, Fraumeni JF (1982) Prospective study of a family cancer syndrome. JAMA 247:2692–2694
Li FP, Fraumeni JF, Mulvihill JJ, et al. (1988) A cancer family syndrome in 24 kindreds. Cancer Res 48:5358–5362
Birch JM, Hartley AL, Tricker KJ, et al. (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54:1298–1304
Malkin D, Li FP, Strong LC, et al. (1990) Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238
Varley JM, McGown G, Thorncroft M, et al. (1997) Germline mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57:3245–3252
Varley JM (2000) Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 2003;21:313–320
The JOA Committee of Tumors (eds) (2000) General rules for clinical and pathological studies on malignant bone tumors (in Japanese). Kanehara, Tokyo, pp 51–68
Matsumoto S, Kawaguchi N, Manabe J, et al. (2002) “In situ preparation”: new surgical procedure indicated for soft-tissue sarcoma of a lower limb in close proximity to major neurovascular structures. Int J Clin Oncol 7:51–56
Beroud C, Soussi T (2003) The UMD-p53 database: new mutations and analysis tools. Hum Mutat 21:176–181
Huusko P, Castren K, Launonen V, et al. (1999) Germline TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2. Cancer Genet Cytogenet 112:9–14
Zuou XP, Sanson M, Hoang-Xuan K, et al. (1999) Germ-line mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. Ann Neurol 46:913–916
Nutting C, Camplejohn RS, Gilchrist R, et al. (2000) A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy? Clin Oncol (R Coll Radiol) 12: 300–304
Fayette J, Blay JY (2005) Genetic predictors for drug resistance in soft tissue sarcoma: a review of publications in 2004. Curr Opin Oncol 17:370–375
Cuddihy AR, Bristow RG (2004) The protein family and radiation sensitivity: yes or no? Cancer Metastasis Rev 23:237–257
Hisada M, Garber JE, Fung CY, et al. (1998) Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 90:606–611
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Izawa, N., Matsumoto, S., Manabe, J. et al. A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene. Int J Clin Oncol 13, 78–82 (2008). https://doi.org/10.1007/s10147-007-0692-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-007-0692-8